| # | Drug | Count |
|---|---|---|
| 0 | ERGOCALCIFEROL | 15 |
| 1 | SOMATROPIN | 13 |
| 2 | METHOTREXATE | 10 |
| 3 | METHOTREXATE SODIUM | 10 |
| 4 | OMEPRAZOLE MAGNESIUM | 10 |
| 5 | ALBUTEROL SULFATE | 9 |
| 6 | OMEPRAZOLE | 9 |
| 7 | FINGOLIMOD HCL | 8 |
| 8 | BUPROPION HYDROCHLORIDE | 7 |
| 9 | CLONAZEPAM | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VORASIDENIB | 1 | 0.0016 |
| 1 | PSYLLIUM HUSK | 1 | 0.0007 |
| 2 | LIDOCAINE AND PRILOCAINE | 1 | 0.0007 |
| 3 | NIZATIDINE | 1 | 0.0007 |
| 4 | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | 1 | 0.0006 |
| 5 | LETERMOVIR | 2 | 0.0006 |
| 6 | CAPLACIZUMAB | 1 | 0.0006 |
| 7 | SATRALIZUMAB | 1 | 0.0006 |
| 8 | ROPEGINTERFERON ALFA-2B | 1 | 0.0005 |
| 9 | LORLATINIB | 4 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 18 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15 |
| 2 | Provitamin D2 Compound [EPC] | 15 |
| 3 | Corticosteroid [EPC] | 14 |
| 4 | Kinase Inhibitor [EPC] | 14 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 10 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 10 |
| 7 | Proton Pump Inhibitor [EPC] | 10 |
| 8 | Atypical Antipsychotic [EPC] | 7 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 2 | 0.0006 |
| 1 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 2 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 3 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 4 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 4 | 0.0004 |
| 5 | mu-Opioid Receptor Agonist [EPC] | 1 | 0.0003 |
| 6 | Interleukin-17A Antagonist [EPC] | 6 | 0.0002 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 8 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |